Search research articles
Contact Us
Filters
Showing results (161-170 of 215) with videos related to
Page
of 22
Sort By:
Journal of Crohn'S & Colitis
|
June 28, 2020
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know
Philipp Schreiner, Nicolas J Mueller, Jan Fehr, et al.
JPGN Reports
|
May 11, 2023
Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort
Thea von Graffenried, Alain M Schoepfer, Jean-Benoit Rossel, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
December 23, 2006
fMLP induces Hsp27 expression, attenuates NF-kappaB activation, and confers intestinal epithelial cell protection
Ryan M Carlson, Stephan R Vavricka, Jyrki J Eloranta, et al.
United European Gastroenterology Journal
|
December 5, 2020
Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort
Thomas Greuter, Frédéric Porchet, Manuel B Braga-Neto, et al.
Inflammatory Bowel Diseases
|
April 22, 2011
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
Stephan R Vavricka, Sabrina M Spigaglia, Gerhard Rogler, et al.
Inflammatory Bowel Diseases
|
November 13, 2013
Periodontitis and gingivitis in inflammatory bowel disease: a case-control study
Stephan R Vavricka, Christine N Manser, Sebastian Hediger, et al.
Inflammatory Intestinal Diseases
|
August 18, 2022
Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
Alain M Schoepfer, Vu Dang Chau Tran, Jean-Benoit Rossel, et al.
Inflammatory Bowel Diseases
|
February 28, 2014
Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis
Natalie Filmann, Julia Rey, Sven Schneeweiss, et al.
Inflammatory Bowel Diseases
|
June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Stephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Alimentary Pharmacology & Therapeutics
|
November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activities
Philipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 215) with videos related to
Sort By:
Page
of 22
Journal of Crohn'S & Colitis
|
June 28, 2020
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know
Philipp Schreiner, Nicolas J Mueller, Jan Fehr, et al.
JPGN Reports
|
May 11, 2023
Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort
Thea von Graffenried, Alain M Schoepfer, Jean-Benoit Rossel, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
December 23, 2006
fMLP induces Hsp27 expression, attenuates NF-kappaB activation, and confers intestinal epithelial cell protection
Ryan M Carlson, Stephan R Vavricka, Jyrki J Eloranta, et al.
United European Gastroenterology Journal
|
December 5, 2020
Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort
Thomas Greuter, Frédéric Porchet, Manuel B Braga-Neto, et al.
Inflammatory Bowel Diseases
|
April 22, 2011
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
Stephan R Vavricka, Sabrina M Spigaglia, Gerhard Rogler, et al.
Inflammatory Bowel Diseases
|
November 13, 2013
Periodontitis and gingivitis in inflammatory bowel disease: a case-control study
Stephan R Vavricka, Christine N Manser, Sebastian Hediger, et al.
Inflammatory Intestinal Diseases
|
August 18, 2022
Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
Alain M Schoepfer, Vu Dang Chau Tran, Jean-Benoit Rossel, et al.
Inflammatory Bowel Diseases
|
February 28, 2014
Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis
Natalie Filmann, Julia Rey, Sven Schneeweiss, et al.
Inflammatory Bowel Diseases
|
June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Stephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Alimentary Pharmacology & Therapeutics
|
November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activities
Philipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Page
of 22